Health care costs and their predictors of inflammatory bowel diseases in Germany

European Journal of Health Economics

Volumn 12, Issue 3, 2011, Pages 273-283

  Prenzler, Anne ^a   Bokemeyer, Bernd ^b   Von Der Schulenburg, J Matthias ^a   Mittendorf, Thomas ^a  

^a LEIBNIZ UNIVERSITY HANNOVER   (Germany)

^b KLINIKUM MINDEN   (Germany)

Author keywords

Cost analyses; Cost of illness; Generalized linear models; Germany; Inflammatory bowel diseases

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; MESALAZINE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; ARTICLE; CONTROLLED STUDY; COST OF ILLNESS; CROHN DISEASE; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; DRUG COST; ECONOMIC ASPECT; ENTERITIS; FEMALE; GERMANY; HEALTH CARE COST; HOSPITAL PATIENT; HUMAN; INTERNET; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PREDICTIVE VALIDITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REGRESSION ANALYSIS; STATISTICAL ANALYSIS; ULCERATIVE COLITIS;

ADULT; BODY MASS INDEX; COHORT STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; GERMANY; HEALTH EXPENDITURES; HEALTH SERVICES; HUMANS; INPATIENTS; MALE; MIDDLE AGED; OUTPATIENTS; PRESCRIPTION DRUGS; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 79958076320     PISSN: 16187598     EISSN: 16187601     Source Type: Journal    
DOI: 10.1007/s10198-010-0281-z     Document Type: Article

References (39)

1. BB Crohn L Ginzburg GD Oppenheimer 1932 Regional ileitis-a pathologic and clinical entity JAMA 99 1323 1329
2. DC Baumgart WJ Sandborn 2007 Inflammatory bowel disease: clinical aspects and established and evolving therapies Lancet 369 1641 1657 17499606 10.1016/S0140-6736(07)60751-X 1:CAS:528:DC%2BD2sXltF2qs74%3D (Pubitemid 46722637)
3. B Bokemeyer 2007 IBD-treatment in Germany Gastroenterologe 2 447 455 10.1007/s11377-007-0113-6
4. JW Brandes H Lorenz-Meyer 1983 Epidemiologic aspects of Crohn regional enterocolitis and ulcerative colitis in Marburg/Lahn (West Germany) between 1962 and 1975 Z. Gastroenterol. 21 69 78 6601887 1:STN:280:DyaL3s7pvFGnsQ%3D%3D (Pubitemid 13154296)
5. W Daiss M Scheurlen H Malchow 1989 Epidemiology of inflammatory bowel disease in the county of Tubingen (West Germany) Scand. J. Gastroenterol. Suppl. 170 39 43 2617191 10.3109/00365528909091349 1:STN:280:DyaK3c7ktVGitw%3D%3D (Pubitemid 20015821)
6. H Goebell E Dirks S Förster, et al. 1994 A prospective analysis of the incidence and prevalence of Crohn's disease in an urban population in Germany Eur. J. Gastroenterol. Hepatol. 6 1039 1045 10.1097/00042737-199411000- 00012 (Pubitemid 24322876)
7. Federal Statistical Office: Costs of illness accounts. Wiesbaden (2008)
8. A Beiche HH Konig M Ebinger, et al. 2003 Costs of ambulant care for patients with inflammatory bowel disease in general practice Z. Gastroenterol. 41 527 536 12806538 10.1055/s-2003-39647 1:STN:280:DC%2BD3s3nvFelug%3D%3D (Pubitemid 36798997)
9. I Blumenstein H Bock C Weber, et al. 2008 Health care and cost of medication for inflammatory bowel disease in the Rhein-Main region, Germany: a multicenter, prospective, internet-based study Inflamm. Bowel Dis. 14 53 60 17973301 10.1002/ibd.20257 1:STN:280:DC%2BD1c%2FmvFWgsg%3D%3D (Pubitemid 351196869)
10. M Ebinger R Leidl S Thomas, et al. 2004 Cost of outpatient care in patients with inflammatory bowel disease in a German University Hospital J. Gastroenterol. Hepatol. 19 192 199 14731130 10.1111/j.1440-1746.2004.03251.x (Pubitemid 38253360)
11. M Rösch R Leidl S Thomas, et al. 2002 Measurement of outpatient treatment costs of chronic inflammatory bowel diseases at a German university hospital Med Klin (Munich) 97 128 136 10.1007/s00063-002-1136-x (Pubitemid 34258791)
12. R Stark HH Konig R Leidl 2006 Costs of inflammatory bowel disease in Germany Pharmacoeconomics 24 797 814 16898849 10.2165/00019053-200624080-00006 (Pubitemid 44232107)
13. M Rösch R Leidl C von Tirpitz, et al. 2002 Cost measurement based on a cost diary in patients with inflammatory bowel disease Z. Gastroenterol. 40 217 228 11961730 10.1055/s-2002-25153 (Pubitemid 34532653)
14. WR Best JM Becktel JW Singleton, et al. 1976 Development of a Crohn's disease activity index. National cooperative Crohn's disease study Gastroenterology 70 439 444 1248701 1:STN:280:DyaE287hvVGmtg%3D%3D
15. D Rachmilewitz 1989 Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial BMJ 298 82 86 2563951 10.1136/bmj.298.6666.82 1:STN:280:DyaL1M7ltVOitg%3D%3D (Pubitemid 19032930)
16. S Braun A Prenzler T Mittendorf, et al. 2009 Appraisal for the valuation of resource use in the German health-care system from the perspective of the statutory health insurance Gesundheitswesen 71 19 23 19173145 10.1055/s-0028-1102930 1:STN:280:DC%2BD1M7gtVGltw%3D%3D
17. National Association of Statutory Health Insurance Physicians: Appendix 3 regarding the resolution of the assessment committee according to § 87 para. 1 SGB V for determining the standard service volumes by the Associations of Statutory Health Insurance Physicians according to § 85 para. 4a SGB V. (2008)
18. JC Hoffmann JC Preiss F Autschbach, et al. 2008 Clinical practice guideline on diagnosis and treatment of Crohn's disease Z. Gastroenterol. 46 1094 1146 18810679 10.1055/s-2008-1027796 1:STN:280:DC%2BD1cnotVGgsw%3D%3D
19. Federal Statistical Office: Diagnosis data of patients in hospitals 2006, Fachserie 12 Reihe 6.2.1. Wiesbaden (2008)
20. InEK GmbH-Institute for the Hospital Remuneration System: G-DRG Definition Handbook, Version 2007. Siegburg (2006)
21. Federal Association of Local Health Care Funds: Overview of the case values in the single federal states (2007)
22. InEK GmbH-Institute for the Hospital Remuneration System: Diagnosis Related Group-Catalogue 2007 (2006)
23. LAUER-FISCHER GmbH. Lauer-Taxe online ( www.lauer-fischer.de )
24. S Dodd A Bassi K Bodger 2006 A comparison of multivariable regression models to analyse cost data J. Eval. Clin. Pract. 12 76 86 16422782 10.1111/j.1365-2753.2006.00610.x (Pubitemid 43219521)
25. RM Nixon SG Thompson 2004 Parametric modelling of cost data in medical studies Stat. Med. 23 1311 1331 15083485 10.1002/sim.1744 1:STN:280: DC%2BD2c7oslerug%3D%3D (Pubitemid 38514826)
26. A O'Hagan JW Stevens 2003 Assessing and comparing costs: how robust are the bootstrap and methods based on asymptotic normality? Health Econ. 12 33 49 12483759 10.1002/hec.699 (Pubitemid 36149858)
27. A Briggs R Nixon S Dixon, et al. 2005 Parametric modelling of cost data: some simulation evidence Health Econ. 14 421 428 15685641 10.1002/hec.941 (Pubitemid 40514754)
28. TB Gibson E Ng RJ Ozminkowski, et al. 2008 The direct and indirect cost burden of Crohn's disease and ulcerative colitis J. Occup. Environ. Med. 50 1261 1272 19001952 10.1097/JOM.0b013e318181b8ca
29. E Hillson S Dybicz HC Waters, et al. 2008 Health care expenditures in ulcerative colitis: the perspective of a self-insured employer J. Occup. Environ. Med. 50 969 977 18695456 10.1097/JOM.0b013e31816fd663
30. S Odes H Vardi M Friger, et al. 2006 Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation Gastroenterology 131 719 728 16952541 10.1053/j.gastro. 2006.05.052 (Pubitemid 44307060)
31. AP Yu LA Cabanilla EQ Wu, et al. 2008 The costs of Crohn's disease in the United States and other Western countries: a systematic review Curr. Med. Res. Opin. 24 319 328 18067689 10.1185/030079908X260790 1:CAS:528: DC%2BD1cXptFKru7Y%3D (Pubitemid 351294380)
32. S Odes 2008 How expensive is inflammatory bowel disease? A critical analysis World J. Gastroenterol. 14 6641 6647 19034966 10.3748/wjg.14.6641
33. MD Kappelman SL Rifas-Shiman CQ Porter, et al. 2008 Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults Gastroenterology 135 1907 1913 18854185 10.1053/j.gastro.2008.09.012
34. M Henriksen J Jahnsen I Lygren, et al. 2007 Clinical course in Crohn's disease: results of a five-year population-based follow-up study (the IBSEN study) Scand. J. Gastroenterol. 42 602 610 17454881 10.1080/00365520601076124 (Pubitemid 46633816)
35. IC Solberg I Lygren J Jahnsen, et al. 2009 Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study) Scand. J. Gastroenterol. 44 431 440 19101844 10.1080/00365520802600961
36. Holtmann, M.H., Krummenauer, F., Claas, C. et al.: Significant differences between Crohn's disease and ulcerative colitis regarding the impact of body mass index and initial disease activity on responsiveness to azathioprine: results from a european multicenter study in 1,176 patients. Dig. Dis. Sci. 55, 1066-1078 (2010)
37. T Brechmann W Schmiegel 2007 Procedure of implementation of new methods of examination and treatment in the G-DRG system (NUB procedure) Med. Klin. (Munich) 102 683 684 10.1007/s00063-007-1088-2 (Pubitemid 47356335)
38. J-M von der Schulenburg W Greiner F Jost, et al. 2008 German recommendations on health economic evaluation: third and updated version of the Hanover consensus Value Health 11 539 544 10.1111/j.1524-4733.2007.00301.x (Pubitemid 352032814)
39. Häussler, B., Höer, A., Hempel, E. et al.: Arzneimittel-Atlas 2009: Der Arzneimittelverbrauch in der GKV. Munich. (2009)